132 related articles for article (PubMed ID: 30294471)
1. Post-stroke mRNA expression profile of MMPs: effect of genetic deletion of MMP-12.
Nalamolu KR; Chelluboina B; Magruder IB; Fru DN; Mohandass A; Venkatesh I; Klopfenstein JD; Pinson DM; Boini KM; Veeravalli KK
Stroke Vasc Neurol; 2018 Sep; 3(3):153-159. PubMed ID: 30294471
[TBL] [Abstract][Full Text] [Related]
2. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.
Tsuji K; Aoki T; Tejima E; Arai K; Lee SR; Atochin DN; Huang PL; Wang X; Montaner J; Lo EH
Stroke; 2005 Sep; 36(9):1954-9. PubMed ID: 16051896
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic application of gene silencing MMP-9 in a middle cerebral artery occlusion-induced focal ischemia rat model.
Hu Q; Chen C; Yan J; Yang X; Shi X; Zhao J; Lei J; Yang L; Wang K; Chen L; Huang H; Han J; Zhang JH; Zhou C
Exp Neurol; 2009 Mar; 216(1):35-46. PubMed ID: 19073180
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stem Cell Treatment Prevents Post-Stroke Dysregulation of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases.
Chelluboina B; Nalamolu KR; Mendez GG; Klopfenstein JD; Pinson DM; Wang DZ; Veeravalli KK
Cell Physiol Biochem; 2017; 44(4):1360-1369. PubMed ID: 29186705
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury.
Gu Y; Zheng G; Xu M; Li Y; Chen X; Zhu W; Tong Y; Chung SK; Liu KJ; Shen J
J Neurochem; 2012 Jan; 120(1):147-56. PubMed ID: 22007835
[TBL] [Abstract][Full Text] [Related]
6. Induced mRNA expression of matrix metalloproteinases Mmp-3, Mmp-12, and Mmp-13 in the infarct cerebral cortex of photothrombosis model mice.
Hohjoh H; Horikawa I; Nakagawa K; Segi-Nishida E; Hasegawa H
Neurosci Lett; 2020 Nov; 739():135406. PubMed ID: 32987131
[TBL] [Abstract][Full Text] [Related]
7. Post-ischaemic silencing of p66Shc reduces ischaemia/reperfusion brain injury and its expression correlates to clinical outcome in stroke.
Spescha RD; Klohs J; Semerano A; Giacalone G; Derungs RS; Reiner MF; Rodriguez Gutierrez D; Mendez-Carmona N; Glanzmann M; Savarese G; Kränkel N; Akhmedov A; Keller S; Mocharla P; Kaufmann MR; Wenger RH; Vogel J; Kulic L; Nitsch RM; Beer JH; Peruzzotti-Jametti L; Sessa M; Lüscher TF; Camici GG
Eur Heart J; 2015 Jul; 36(25):1590-600. PubMed ID: 25904764
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.
Romanic AM; White RF; Arleth AJ; Ohlstein EH; Barone FC
Stroke; 1998 May; 29(5):1020-30. PubMed ID: 9596253
[TBL] [Abstract][Full Text] [Related]
9. Macrophage infiltration and renal damage are independent of matrix metalloproteinase 12 in the obstructed kidney.
Abraham AP; Ma FY; Mulley WR; Ozols E; Nikolic-Paterson DJ
Nephrology (Carlton); 2012 May; 17(4):322-9. PubMed ID: 22257277
[TBL] [Abstract][Full Text] [Related]
10. Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits MMP-9-mediated blood-brain-barrier breakdown in a mouse model for ischemic stroke.
Ludewig P; Sedlacik J; Gelderblom M; Bernreuther C; Korkusuz Y; Wagener C; Gerloff C; Fiehler J; Magnus T; Horst AK
Circ Res; 2013 Sep; 113(8):1013-22. PubMed ID: 23780386
[TBL] [Abstract][Full Text] [Related]
11. Complexity in differentiating the expression of truncated or matured forms of MMP-2 and MMP-9 through zymography in rat brain tissues after acute ischaemic stroke.
Alam M; Shuaib A
J Neurosci Methods; 2013 May; 216(1):22-7. PubMed ID: 23523510
[TBL] [Abstract][Full Text] [Related]
12. Matrix Metalloproteinase-2 (MMP-2) Gene Deletion Enhances MMP-9 Activity, Impairs PARP-1 Degradation, and Exacerbates Hepatic Ischemia and Reperfusion Injury in Mice.
Kato H; Duarte S; Liu D; Busuttil RW; Coito AJ
PLoS One; 2015; 10(9):e0137642. PubMed ID: 26355684
[TBL] [Abstract][Full Text] [Related]
13. Deletion of the ageing gene p66(Shc) reduces early stroke size following ischaemia/reperfusion brain injury.
Spescha RD; Shi Y; Wegener S; Keller S; Weber B; Wyss MM; Lauinger N; Tabatabai G; Paneni F; Cosentino F; Hock C; Weller M; Nitsch RM; Lüscher TF; Camici GG
Eur Heart J; 2013 Jan; 34(2):96-103. PubMed ID: 23008506
[TBL] [Abstract][Full Text] [Related]
14. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
[TBL] [Abstract][Full Text] [Related]
15. Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat: effects on BBB breakdown and MMP expression in the acute and subacute phase.
Nagel S; Su Y; Horstmann S; Heiland S; Gardner H; Koziol J; Martinez-Torres FJ; Wagner S
Brain Res; 2008 Jan; 1188():198-206. PubMed ID: 18031717
[TBL] [Abstract][Full Text] [Related]
16. Matrix Metalloproteinase-12 Induces Blood-Brain Barrier Damage After Focal Cerebral Ischemia.
Chelluboina B; Klopfenstein JD; Pinson DM; Wang DZ; Vemuganti R; Veeravalli KK
Stroke; 2015 Dec; 46(12):3523-31. PubMed ID: 26534974
[TBL] [Abstract][Full Text] [Related]
17. Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia.
Fujimoto M; Takagi Y; Aoki T; Hayase M; Marumo T; Gomi M; Nishimura M; Kataoka H; Hashimoto N; Nozaki K
J Cereb Blood Flow Metab; 2008 Oct; 28(10):1674-85. PubMed ID: 18560439
[TBL] [Abstract][Full Text] [Related]
18. Strain variation in response to lung ischemia: role of MMP-12.
Tankersley CG; Moldobaeva A; Wagner EM
Respir Res; 2012 Oct; 13(1):93. PubMed ID: 23061826
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment.
Montaner J; Alvarez-Sabín J; Molina C; Anglés A; Abilleira S; Arenillas J; González MA; Monasterio J
Stroke; 2001 Aug; 32(8):1759-66. PubMed ID: 11486102
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin and calpain inhibitor E64d attenuates matrix metalloproteinase-9 activity after focal cerebral ischemia in rats.
Tsubokawa T; Solaroglu I; Yatsushige H; Cahill J; Yata K; Zhang JH
Stroke; 2006 Jul; 37(7):1888-94. PubMed ID: 16763180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
